Iten, the French company known for its all-solid-state micro-batteries, has taken a new step toward medical implants by adapting its technology for class III implantable devices. The goal is to make implanted systems more compact, safer, and wirelessly rechargeable, with a first target application in cardiac support.
Unlike conventional batteries, Iten’s technology uses no liquid electrolyte, a design choice that is central to its pitch for medical use. The company says this solid-state approach can better suit highly constrained implant environments, where size, reliability, and safety are critical. By removing the liquid component, Iten aims to reduce risks associated with leakage while enabling smaller form factors and wireless charging capabilities.
The announcement marks an important milestone for the French startup, which has been building its expertise in micro-batteries based on “all-solid” technology. Its move into class III implants — the most demanding category of medical devices — suggests the company is positioning itself for applications where battery performance and long-term safety are especially sensitive, such as devices assisting heart function.
The first concrete use case mentioned is cardiac assistance, indicating that Iten is targeting one of the most stringent and high-value segments of implantable medical technology. If successful, the adaptation could help enable a new generation of implanted devices that are less bulky, easier to maintain, and capable of wireless recharging, potentially improving both patient comfort and device longevity.